ADVANCED BIO-POLYMEER TECHNOLOGIES: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
ADVANCED BIO-POLYMEER TECHNOLOGIES
Largest movements
- Cash -€15
down €15 (-91.4%), from €16 to €1
mainly Debts after one year (-€48,722)
- Debts after one year -€48,722
down €48,722 (-8.9%), from €550,381 to €501,659
- Profit (loss) carried forward +€47,091
up €47,091 (+2.5%), from -€1.9m to -€1.8m
- Trade debts +€945
up €945 (+7.2%), from €13,115 to €14,060
- Other debts +€671
up €671 (+7.5%), from €8,998 to €9,669
- Financial income +€48,722
up €48,722, from €0 to €48,722
- Financial charges -€23,885
down €23,885 (-99.8%), from €23,929 to €44
- Other operating charges -€118
down €118 (-100%), from €118 to €0
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €16 | €1 | -€15 | -91.4% |
| Current assets | 29/58 | €16 | €1 | -€15 | -91.4% |
| Cash at bank and in hand | 54/58 | €16 | €1 | -€15 | -91.4% |
| Total equity and liabilities | 10/49 | €16 | €1 | -€15 | -91.4% |
| Equity | 10/15 | -€577,478 | -€530,387 | +€47,091 | +8.2% |
| Contributions | 10/11 | €1,274,000 | €1,274,000 | = | 0.0% |
| Capital | 10 | €62,000 | €62,000 | = | 0.0% |
| Issued capital | 100 | €62,000 | €62,000 | = | 0.0% |
| Contributions outside capital | 11 | €1,212,000 | €1,212,000 | = | 0.0% |
| Share premium | 1100/10 | €1,212,000 | €1,212,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€1,851,478 | -€1,804,387 | +€47,091 | +2.5% |
| Provisions and deferred taxes | 16 | €5,000 | €5,000 | = | 0.0% |
| Provisions for liabilities and charges | 160/5 | €5,000 | €5,000 | = | 0.0% |
| Other liabilities and charges | 164/5 | €5,000 | €5,000 | = | 0.0% |
| Amounts payable | 17/49 | €572,494 | €525,388 | -€47,106 | -8.2% |
| Amounts payable after more than one year | 17 | €550,381 | €501,659 | -€48,722 | -8.9% |
| Financial debts | 170/4 | €550,381 | €501,659 | -€48,722 | -8.9% |
| Amounts payable within one year | 42/48 | €22,113 | €23,729 | +€1,616 | +7.3% |
| Trade debts | 44 | €13,115 | €14,060 | +€945 | +7.2% |
| Suppliers | 440/4 | €13,115 | €14,060 | +€945 | +7.2% |
| Other amounts payable | 47/48 | €8,998 | €9,669 | +€671 | +7.5% |
| Other operating charges | 640/8 | €118 | €0 | -€118 | -100% |
| Gross operating margin | 9900 | -€1,574 | -€1,587 | -€14 | -0.9% |
| Operating profit (loss) | 9901 | -€1,692 | -€1,587 | +€104 | +6.2% |
| Financial income | 75/76B | €0 | €48,722 | +€48,722 | |
| Recurring financial income | 75 | €0 | €48,722 | +€48,722 | |
| Financial charges | 65/66B | €23,929 | €44 | -€23,885 | -99.8% |
| Recurring financial charges | 65 | €23,929 | €44 | -€23,885 | -99.8% |
| Profit (loss) for the period before taxes | 9903 | -€25,621 | €47,091 | +€72,712 | |
| Profit (loss) for the period | 9904 | -€25,621 | €47,091 | +€72,712 | |
| Profit (loss) for the period to be appropriated | 9905 | -€25,621 | €47,091 | +€72,712 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 27 October 2026 via checked.be.